Gene polymorphisms leading to calcified and stenotic aortic valves;Genpolymorphismus bei der verkalkten Aortenklappenstenose

Herz

Volumn 31, Issue 7, 2006, Pages 635-643

  Anger, Thomas ^a,b   Ekici, Arif B ^a   Daniel, Werner G ^a   Garlichs, Christoph D ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Aortic valve stenosis; Chromosomal translocations; Genetic determinates; Genetic mutations

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHEMOKINE RECEPTOR; CONNECTIVE TISSUE GROWTH FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ELASTIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR ALPHA; GLUCOSYLCERAMIDASE; INTERLEUKIN 10; NOTCH1 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; VITAMIN D RECEPTOR;

AORTA VALVE STENOSIS; ARTERY CALCIFICATION; ARTICLE; AUTOSOMAL INHERITANCE; CAUCASIAN; CHROMOSOME ABERRATION; DIGEORGE SYNDROME; DNA POLYMORPHISM; FALLOT TETRALOGY; FRAGILE X SYNDROME; GAUCHER DISEASE; GENE EXPRESSION; GENE MUTATION; HEART VALVE REPLACEMENT; HUMAN; MITRAL VALVE DISEASE; PATHOPHYSIOLOGY; PREVALENCE; TRISOMY; TURNER SYNDROME; WILLIAMS BEUREN SYNDROME;

AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; CHROMOSOME ABERRATIONS; FEMALE; GAUCHER DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; POLYMORPHISM, GENETIC; SEX CHROMOSOMES; TETRALOGY OF FALLOT; TRANSLOCATION, GENETIC; TURNER SYNDROME; WILLIAMS SYNDROME; X CHROMOSOME;

EID: 33750572120     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-006-2881-z     Document Type: Article

References (65)

1. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316-26.
2. Garg V. Molecular genetics of aortic valve disease. Curr Opin Cardiol 2006;21:180-4.
3. Makkena B, Salti H, Subramaniam M, et al. Atorvastatin decreases cellular proliferation and bone matrix expression in the hypercholesterolemic mitral valve. J Am Coll Cardiol 2005;45:631-3.
4. Rajamannan NM, Subramaniam M, Caira F, et al. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation 2005;112:I229-34.
5. Kaden JJ, Dempfle CE, Grobholz R, et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc Pathol 2005;14:80-7.
6. Kaden JJ, Bickelhaupt S, Grobholz R, et al. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis. J Heart Valve Dis 2004;13:560-6.
7. Kaden JJ, Dempfle CE, Kilic R, et al. Influence of receptor activator of nuclear factor kappa B on human aortic valve myofibroblasts. Exp Mol Pathol 2005;78:36-40.
8. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2389-97.
9. Eberle P, Beuren AJ. Chromosome studies in patients with supravalvular aortic stenosis. Lancet 1963;13:438.
10. Bharati S, Lev M. Congenital polyvalvular disease. Circulation 1973;47:575-86.
11. Logan WF, Jones EW, Walker E, et al. Familial supravalvar aortic stenosis. Br Heart J 1965;27:547-59.
12. Schieche M. [Familial occurrence of congenital angiocardiopathies.] Z Gesamte Inn Med 1970;25:1103-8.
13. Trost D, Engels H, Bauriedel G, et al. [Congenital cardiovascular malformations and chromosome microdeletions in 22q11.2.] Dtsch Med Wochenschr 1999;124:3-7.
14. Sreeram N, Wren C, Bhate M, et al. Cardiac abnormalities in the fragile X syndrome. Br Heart J 1989;61:289-91.
15. Monteleone PL, Fagan LF. Possible X-linked congenital heart disease. Circulation 1969;39:611-4.
16. Waldstein G, Hagerman R. Aortic hypoplasia and cardiac valvular abnormalities in a boy with fragile X syndrome. Am J Med Genet 1988;30:83-98.
17. Grimm T, Wesselhoeft H. [The genetic aspects of Williams-Beuren syndrome and the isolated form of the supravalvular aortic stenosis. Investigation of 128 families (author's translation).] Z Kardiol 1980;69:168-72.
18. Nickerson E, Greenberg F, Keating MT, et al. Deletions of the elastin gene at 7q11.23 occur in approximately 90% of patients with Williams syndrome. Am J Hum Genet 1995; 56:1156-61.
19. Olson TM, Michels VV, Lindor NM, et al. Autosomal dominant supravalvular aortic stenosis: localization to chromosome 7. Hum Mol Genet 1993;2:869-73.
20. Keating MT. Genetic approaches to cardiovascular disease. Supravalvular aortic stenosis, Williams syndrome, and long-QT syndrome. Circulation 1995;92:142-7.
21. Ewart AK, Morris CA, Atkinson D, et al. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat Genet 1993;5:11-6.
22. Urban Z, Kiss E, Kadar K, et al. [Genetic diagnosis of Williams syndrome.] Orv Hetil 1997;138:1749-52.
23. Dadelszen P von, Chitayat D, Winsor EJ, et al. De novo 46,XX,t(6;7)(q27;q11:23) associated with severe cardiovascular manifestations characteristic of supravalvular aortic stenosis and Williams syndrome. Am J Med Genet 2000;90:270-5.
24. George R, McMahon J, Lytle B, et al. Severe valvular and aortic arch calcification in a patient with Gaucher's disease homozygous for the D409H mutation. Clin Genet 2001;59:360-3.
25. Bohlega S, Kambouris M, Shahid M, et al. Gaucher disease with oculomotor apraxia and cardiovascular calcification (Gaucher type IIIC). Neurology 2000;54:261-3.
26. Chabas A, Cormand B, Grinberg D, et al. Unusual expression of Gaucher's disease: cardiovascular calcifications in three sibs homozygous for the D409H mutation. J Med Genet 1995;32:740-2.
27. Lindsay EA, Baldini A. Congenital heart defects and 22q11 deletions: which genes count? Mol Med Today 1998;4:350-7.
28. Marino B, Mileto F, Digilio MC. Tetralogy of Fallot with aortic valvular stenosis and deletion 22q11. Ann Thorac Surg 2003;75:2010-1, author reply 1.
29. Eldadah ZA, Hamosh A, Biery NJ, et al. Familial tetralogy of Fallot caused by mutation in the jagged1 gene. Hum Mol Genet 2001;10:163-9.
30. Ino T, Yabuta K, Okada R. Rare association of tetralogy of Fallot and aortic valve stenosis. Autopsy findings after failed balloon aortic valvuloplasty. Jpn Heart J 1992;33:125-30.
31. Aru GM, Juraszek A, Moskowitz I, et al. Tetralogy of Fallot with congenital aortic valvar stenosis: the tetralogy-truncus interrelationship. Pediatr Cardiol 2006;27:354-9.
32. Sharma J, Friedman D, Schiller M, et al. Aortic stenosis in hypoplastic right heart syndrome, associated with interstitial deletion of chromosome 2. Int J Cardiol 1997;62:199-202.
33. Ho NK, Ng IS. Deletion of the terminal segment of the long arm of chromosome 4 with aortic stenosis. J Paediatr Child Health 1993;29:473-5.
34. Van Praagh S, Truman T, Firpo A, et al. Cardiac malformations in trisomy-18: a study of 41 postmortem cases. J Am Coll Cardiol 1989;13:1586-97.
35. Gotzsche CO, Krag-Olsen B, Nielsen J, et al. Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch Dis Child 1994;71:433-6.
36. Tissieres P, Didier D, Dahoun S, et al. Turner syndrome with complex mosaic monosomy and structural aorta anomalies. J Pediatr 2003;142:341.
37. Prandstraller D, Mazzanti L, Picchio FM, et al. Turner's syndrome: cardiologic profile according to the different chromosomal patterns and long-term clinical follow-up of 136 nonpreselected patients. Pediatr Cardiol 1999;20:108-12.
38. Ortlepp JR, Schmitz F, Mevissen V, et al. The amount of calcium-deficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosis. Eur Heart J 2004;25:514-22.
39. Lewin MB, Otto CM. The bicuspid aortic valve: adverse outcomes from infancy to old age. Circulation 2005;111:832-4.
40. Cripe L, Andelfinger G, Martin LJ, et al. Bicuspid aortic valve is heritable. J Am Coll Cardiol 2004;44:138-43.
41. Gelb BD, Zhang J, Sommer RJ, et al. Familial patent ductus arteriosus and bicuspid aortic valve with hand anomalies: a novel heart-hand syndrome. Am J Med Genet 1999;87:175-9.
42. Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH1 cause aortic valve disease. Nature 2005;437:270-4.
43. Mohamed SA, Hanke T, Schlueter C, et al. Ubiquitin fusion degradation 1-like gene dysregulation in bicuspid aortic valve. J Thorac Cardiovasc Surg 2005;130:1531-6.
44. Nakagawa M, Okamoto N, Fujino H, et al. Tetracuspid aortic valve in a patient with 22q11.2 microdeletion. Am J Med Genet 2000;93:74-5.
45. Chen B, Bronson RT, Klaman LD, et al. Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat Genet 2000;24:296-9.
46. Chowdhury T, Reardon W. Elastin mutation and cardiac disease. Pediatr Cardiol 1999;20:103-7.
47. Curran ME, Atkinson DL, Ewart AK, et al. The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell 1993;73:159-68.
48. Li DY, Toland AE, Boak BB, et al. Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosis. Hum Mol Genet 1997;6:1021-8.
49. Urban Z, Michels VV, Thibodeau SN, et al. Supravalvular aortic stenosis: a splice site mutation within the elastin gene results in reduced expression of two aberrantly spliced transcripts. Hum Genet 1999;104:135-42.
50. Urban Z, Csiszar K, Fekete G, et al. A tetranucleotide repeat polymorphism within the human elastin gene (ELNi1). Clin Genet 1997;51:133-4.
51. Urban Z, Michels VV, Thibodeau SN, et al. Isolated supravalvular aortic stenosis: functional haploinsufficiency of the elastin gene as a result of nonsense-mediated decay. Hum Genet 2000;106:577-88.
52. Boeckel T, Dierks A, Vergopoulos A, et al. A new mutation in the elastin gene causing supravalvular aortic stenosis. Am J Cardiol 1999;83:1141-3, A9-10.
53. Olson TM, Michels VV, Urban Z, et al. A 30 kb deletion within the elastin gene results in familial supravalvular aortic stenosis. Hum Mol Genet 1995;4:1677-9.
54. Morris CA, Loker J, Ensing G, et al. Supravalvular aortic stenosis cosegregates with a familial 6;7 translocation which disrupts the elastin gene. Am J Med Genet 1993;46:737-44.
55. Wu WJ, Weiss AS. Deficient coacervation of two forms of human tropoelastin associated with supravalvular aortic stenosis. Eur J Biochem 1999;266:308-14.
56. Dellgren G, Eriksson MJ, Blange I, et al. Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis. Am J Cardiol 1999;84:909-13.
57. Chou HT, Chen CH, Tsai CH, et al. Association between transforming growth factor-beta1 gene C-509T and T869C polymorphisms and rheumatic heart disease. Am Heart J 2004;148:181-6.
58. Uyama E, Takahashi K, Owada M, et al. Hydrocephalus, corneal opacities, deafness, valvular heart disease, deformed toes and leptomeningeal fibrous thickening in adult siblings: a new syndrome associated with beta-glucocerebrosidase deficiency and a mosaic population of storage cells. Acta Neurol Scand 1992;86:407-20.
59. Chou HT, Tsai CH, Tsai FJ. Association between angiotensin I-converting enzyme gene insertion/deletion polymorphism and risk of rheumatic heart disease. Jpn Heart J 2004;45:949-57.
60. Nordstrom P, Glader CA, Dahlen G, et al. Oestrogen receptor alpha gene polymorphism is related to aortic valve sclerosis in postmenopausal women. J Intern Med 2003;254:140-6.
61. Ortlepp JR, Hoffmann R, Ohme F, et al. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 2001;85:635-8.
62. Avakian SD, Annicchino-Bizzacchi JM, Grinberg M, et al. Apolipoproteins AI, B, and E polymorphisms in severe aortic valve stenosis. Clin Genet 2001;60:381-4.
63. Anger T, Ensminger S, Fischlein T, et al. Gene-Profiling: Inflammation als Trigger der verkalkten und stenosierten Aortenklappensklerose. Clin Res Cardiol 2006;Suppl 5(95).
64. Yetkin U, Bal F, Bayata S, et al. Severely calcified valvular aortic stenosis firstly diagnosed in monozygotic male twins with suspected Williams-Beuren syndrome. Jpn Heart J 2004;45:877-83.
65. Colley A, Thakker Y, Ward H, et al. Unbalanced 13;18 translocation and Williams syndrome. J Med Genet 1992;29:63-5.